Extracorporeal Shock Wave Lithotripsy Market – Growth, Trends, Covid-19 Impact, And Forecasts (2022-2027)

The Extracorporeal Shock Wave Lithotripsy Market is Segmented by Technology (Electromagnetic, Electrohydraulic, Piezoelectric), Application (Kidney Stone, Pancreatic Stone, Other), End-use (Hospital, Clinic, Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The report offers the value (USD million) for the above segments.

Market Snapshot

Extracorporeal Shock Wave Lithotripsy Market
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: North America
Largest Market: Asia-Pacific
CAGR: 6.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Extracorporeal Shock Wave Lithotripsy Market is expected to grow at the registered CAGR of 6.6% during the forecast period, 2022-2027.

The COVID-19 pandemic has significantly impacted the extracorporeal shock wave lithotripsy market, as anesthesiologists were required to manage COVID-19-infected patients, forcing them to forego elective surgery. The number of beds used for urological patients had to be reduced to provide dedicated beds and personnel for the new COVID-19 wards. Moreover, according to the study titled "COVID-19 pandemic and its effect on supra-regional extracorporeal shock wave lithotripsy (ESWL) service," published in the Journal of EndoUrology in October 2021, because of the limited access to the operating room, non-invasive treatments became an important part of patient management during the lockdown period and complications, all while reducing COVID-19-related risks to the patient.

The extracorporeal shock wave lithotripsy market is expected to be fueled by the rising prevalence and incidences of kidney and ureter stones and increasing demand for minimally invasive procedures. According to the study titled " Risk factors of kidney stone disease: a cross-sectional study in the southeast of Iran," published in the BMC Urology in October 2021, kidney stones affect about 5% of women and 12% of men at some point in their lives. However, 16 percent of kidney stones recurred after one year, followed by 33 percent after five years, and 53 percent after ten years. Using ESWL to treat kidney stones is a safe and effective method of delivering shock waves, and the rising prevalence of kidney stones is expected to increase demand for it, boosting the market.

Moreover, the rising prevalence of obesity and diabetes and patient awareness of recent technological advancements will contribute to the market's expansion. According to the World Health Organization's report published in June 2021, 39 million children under 5 years were overweight or obese in 2020. One in five children and adolescents globally are overweight. Incidences of obesity have been increasing fiercely over the past decades, and it is often described as a global endemic, especially in developed countries where lifestyle-related disorders, such as anxiety, stress, smoking, and drinking, are more prevalent.

In addition, product and service launches, mergers, and acquisitions are expected to boost the market over the forecast period. In October 2020, Extracorporeal Shock Wave Lithotripsy (ESWL) was introduced at M Yunus Regional Hospital in Bengkulu, Indonesia, to provide better health care to the people of Bengkulu.

Furthermore, manufacturers' efforts to produce technologically improved items and expedite product approvals propel the market ahead. For instance. in September 2019, Dornier MedTech introduced OptiVision technology for the Dornier Delta III, an extracorporeal shock wave lithotripsy machine (ESWL). The OptiVision is the first image processing software designed to improve kidney stone treatment efficiency, i.e., visualization of the steps of processing the kidney stone during extracorporeal shock wave lithotripsy, which may aid in more successful treatment.

Thus, all aforementioned factors are expected to boost the market over the forecast period. However, extracorporeal shock wave lithotripsy (ESWL) limitations may restraint the market over the forecast period.

Scope of the Report

Extracorporeal shock wave lithotripsy is a technique for treating stones in the kidney and ureter that does not require surgery. Instead, high-energy shock waves are passed through the body and used to break stones into pieces as small as grains of sand. The extracorporeal shock wave lithotripsy devices (ESWL) are used to treat kidney and ureter stones. This technology has been utilized by physicians worldwide. It is expected to increase its penetration over the coming years due to its advantages, such as minimal invasiveness, reduced pain, shorter hospital stay, and quicker recovery. The Extracorporeal Shock Wave Lithotripsy Market is Segmented by Technology (Electromagnetic, Electrohydraulic, Piezoelectric), Application (Kidney Stone, Pancreatic Stone, Other), End-use (Hospital, Clinic, Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD million) for the above segments.

Technology
Electromagnetic
Electrohydraulic
Piezoelectric
Application
Kidney Stone
Pancreatic Stone
Other
End-use
Hospital
Clinic
Other
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World

Report scope can be customized per your requirements. Click here.

Key Market Trends

Kidney Stone Segment is Projected to Grow Significantly During the Forecast Period.

The kidney stone segment had the highest revenue share due to the rising prevalence of kidney stones and their recurrence over time, as well as the rising risk factors that cause kidney stones, such as diabetes, obesity, metabolic disorders, intestinal injury, and certain medications.

According to the article published in the Urology Annals in March 2020 by Nada Yasser Baatiah, Nephrolithiasis, or kidney stone disease, is also known as urolithiasis. Urolithiasis was prevalent in 11.2 %, with 48.8 % having a family history with a first-degree relative with the disease. Urolithiasis is 1.8 times more common in men than in women.​

Additionally, according to the International Federation of Diabetics report 2021, diabetes affected approximately 463 million persons aged 20 to 79 years worldwide in 2020. This number is anticipated to climb to 643 million by 2030 and 700 million by 2045. In most countries, the proportion of people with Type 2 diabetes is increasing, and diabetes affects 79% of adults in low- and middle-income countries. A kidney stone can be especially troublesome for people with diabetes because sugar in the urine serves as a breeding ground for bacteria. Therefore, the increasing prevalence of diabetes and kidney stone segment is expected to boost over the forecast period.

Extracorporeal shock wave lithotripsy is a popular kidney stone treatment. It works by shattering a kidney stone into small fragments that can pass through the urinary tract more quickly and exit the body. However, the introduction of the technologically advanced product by key market players is anticipated to boost the market over the forecast period. For instance, in June 2020, Olympus' SoltiveTM SuperPulsed Laser System (Soltive Laser System) is a new thulium fiber laser application designed for stone lithotripsy and soft tissue applications.

Thus, owing to the abovementioned factors, the studied segment is expected to grow significantly over the forecast period

Extracorporeal Shock Wave Lithotripsy Market

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the extracorporeal shock wave lithotripsy market over the forecast period, owing to many obese and diabetic patients prone to stone formation.

The COVID-19 pandemic has had a negative impact on the extracorporeal shock wave lithotripsy market due to the reduced number of surgeries being performed, resulting in reduced usage of the devices. The pandemic also affected the market by directly affecting production and demand by creating supply chain and market disruptions and negatively impacting firms and financial markets.

According to the study published in the American Academy of Family Physicians (AAFP), in March 2020, by Leonardo Ferreira, kidney stones were a common ailment, with an annual incidence of eight instances per 1,000 persons. As per the same source, around 13% of men and 7% of women may develop a kidney stone during their lifetime, and the total incidence of urinary retention in the US is 4.5 to 6.8 per 1,000 men per year.​

However, the rising adoption of extracorporeal shock wave lithotripsy and regulatory approval for the various treatment are boosting the market growth. In February 2021, the Shockwave intravascular lithotripsy (IVL) system was cleared by the US Food and Drug Administration to treat severely calcified coronary artery plaques.

Thus, owing to the abovementioned factors, the studied market is expected to grow significantly over the forecast period

Extracorporeal Shock Wave Lithotripsy Market

Competitive Landscape

The extracorporeal shock wave lithotripsy market is competitive. The key market players operating in lithotripsy devices are EDAP TMS, Corporation, Olympus Corporation, and DirexGroup, among others. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them strengthen their market positions. Furthermore, companies are also focusing on increasing the applications of ESWL devices to strengthen their positions over the forecast period.

Recent Developments

· In January 2022, Applaud Medical received Food and Drug Administration breakthrough device designation for its Acoustic Enhancer technology. Acoustic Enhancer technology for use in conjunction with ureteroscopy with laser lithotripsy (URS-LL) for the fragmentation of calcium-based urinary stones.

· In September 2021, Boston Scientific acquired Lumenis LTD., a privately-held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA). The Lumenis surgical business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures, with total revenue anticipated to be approximately USD 200 million.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Adoption of Minimally Invasive Procedures

      2. 4.2.2 Growing Risk Factors That Lead to Kidney Stones

    3. 4.3 Market Restraints

      1. 4.3.1 Limitations Of Extracorporeal Shock Wave Lithotripsy (ESWL)

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value USD million)

    1. 5.1 Technology

      1. 5.1.1 Electromagnetic

      2. 5.1.2 Electrohydraulic

      3. 5.1.3 Piezoelectric

    2. 5.2 Application

      1. 5.2.1 Kidney Stone

      2. 5.2.2 Pancreatic Stone

      3. 5.2.3 Other

    3. 5.3 End-use

      1. 5.3.1 Hospital

      2. 5.3.2 Clinic

      3. 5.3.3 Other

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Rest of the World

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Cook Medical

      2. 6.1.2 Siemens Healthcare GmbH

      3. 6.1.3 Olympus

      4. 6.1.4 Dornier MedTech

      5. 6.1.5 Storz Medical AG

      6. 6.1.6 MTS Medical

      7. 6.1.7 WIKKON

      8. 6.1.8 Richard-Wolf

      9. 6.1.9 DirexGroup

      10. 6.1.10 EDAP TMS

      11. 6.1.11 Allengers

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Extracorporeal Shock Wave Lithotripsy Market market is studied from 2019 - 2027.

The Global Extracorporeal Shock Wave Lithotripsy Market is growing at a CAGR of 6.6% over the next 5 years.

North America is growing at the highest CAGR over 2021- 2026.

Asia-Pacific holds highest share in 2021.

Olympus, Dornier MedTech, MTS Medical, Cook Medical , Richard-Wolf are the major companies operating in Global Extracorporeal Shock Wave Lithotripsy Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!